• 1
    Singal A., Khanna D. (2011) Onychomycosis: diagnosis and management. Indian J Dermatol Venereol Leprol 77: 65972.
  • 2
    Siu J.J.W., Tatsumi Y., Senda H., Pillai R., Nakamura T., Sone D., Fothergill A. (2013) Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis. Antimicrobial Agents Ch 57: 16106.
  • 3
    Lecha M. (2001) Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trail in Spain. Brit J Dermatol 145: 216.
  • 4
    Elewski B.E. (2000) Onychomycosis. Treatment, quality of life, and economic issues. Am J Clin Dermatol 1: 1926.
  • 5
    Baran R., Feuilhade M., Datry A., Goettmann S., Pietrini P., Viguie C., Badillet G., Larnier C., Czernielewski J. (2000) A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region. Brit J Dermatol 142: 117783.
  • 6
    Harman S., Ashbee H.R., Evans E.G. (2004) Testing of antifungal combinations against yeasts and dermatophytes. J Dermatolog Treat 15: 1047.
  • 7
    Gupta A.K., Kohli Y. (2003) In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes, and in vitro evaluation of combination antifungal activity. Brit J Dermatol 149: 296305.
  • 8
    Sim Y., Shin S. (2008) Combinatorial anti-Trichophyton effects of Ligusticum chuanxiong essential oil components with antibiotics. Arch Pharm Res 31: 487502.
  • 9
    Santos D.A., Hamdan J.S. (2006) In vitro antifungal oral drug and drug-combination activity against onychomycosis causative dermatophytes. Med Mycol 44: 35762.
  • 10
    Silva L.B., de Oliveira D.B., da Silva B.V., de Souza R.A., da Silva P.R., Ferreira-Paim K., Andrade-Silva L.E., Silva-Vergara M.L., Andrade A.A. (2013) Identification and antifungal susceptibility of fungi isolated from dermatomycoses. J Eur Acad Dermatol Venereol doi: 10.1111/jdv.12151.
  • 11
    Harada T. (2011) Tinea unguium. Med Mycol J 52: 7795.
  • 12
    Gupta A.K., Cooper E.A., Paquet M. (2013) Recurrences of dermatophyte toenail onychomycosis during long-term follow-up after successful treatments with mono- and combined therapy of terbinafine and itraconazole. J Cutan Med Surg 17: 2016.
  • 13
    Welsh O., Vera-Cabrera L., Welsh E. (2010) Onychomycosis. Clin Dermatol 28: 1519.
  • 14
    Lurati M., Baudraz-Rosselet F., Vernez M., Spring P., Bontems O., Fratti M., Monod M. (2011) Efficacious treatment of non-dermatophyte mould onychomycosis with topical amphotericin B. Dermatology 223: 28992.
  • 15
    Farwa U., Abbasi S.A., Mirza I.A., Amjad A., Ikram A., Malik N., Hanif F. (2011) Non-dermatophyte moulds as pathogens of onychomycosis. J Coll Physicians Surg Pak 21: 597600.
  • 16
    Jones T., Tavakkol A. (2013) Safety and tolerability of luliconazole solution 10-percent in patients with moderate to severe distal subungual onychomycosis. Antimicrob Agents Ch 57: 26849.
  • 17
    Ranawaka R.R., Silva N., Ragunathan R.W. (2012) Non-dermatophyte mold onychomycosis in Sri Lanka. Dermatol Online J 18: 7.
  • 18
    Makimura K., Mochizuki T., Hasegawa A., Uchida K., Saito H., Yamaguchi H. (1998) Phylogenetic classification of Trichophyton mentagrophytes complex strains based on DNA sequences of nuclear ribosomal internal transcribed spacer 1 regions. J Clin Microbiol 36: 262933.
  • 19
    Graser Y., Scott J., Summerbell R. (2008) The new species concept in dermatophytes-a polyphasic approach. Mycopathologia 166: 23956.
  • 20
    Makimura K., Tamura Y., Mochizuki T., Hasegawa A., Tajiri Y., Hanazawa R., Uchida K., Saito H., Yamaguchi H. (1999) Phylogenetic classification and species identification of dermatophyte strains based on DNA sequences of nuclear ribosomal internal transcribed spacer 1 regions. J Clin Microbiol 37: 9204.
  • 21
    Sugita C., Makimura K., Murakami A., Murai Y., Yamaguchi H., Nagai A. (2003) A case of pulmonary aspergilloma molecular biological identification and typing of the isolates from antemortem sputa and autopsy fungus ball. Mycoses 246: 14952.
  • 22
    Rex J.H., Alexander B.D., Andes D., Arthington-Skaggs B., Brown S.D., Chaturveli V., Espinel-Ingroff A., Ghannoum M.A., Knapp C.C., Motyl M.R., Ostrosky-Zeichner L., Pfaller M., Sheehan D.J., Walsh T.J. (2008). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi. Approved Standard Second Edition, M38-A2. Wayne: Clinical and Laboratory Standards Institute.
  • 23
    Barchiesi F., Silvestri C., Arzeni D., Ganzetti G., Castelletti S., Simonetti O., Cirioni O., Kamysz W., Kamysz E., Spreghini E., Abruzzetti A., Riva A., Offidani A.M., Giacometti A., Scalise G. (2009) In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents. Med Mycol 47: 3216.
  • 24
    Atef S., Pranab K., Mahmoud A. (2008) Comparison between Standardized Clinical and Laboratory Standards Institute M38-A2 method and a 2,3-bis(2-methoxy-4-nitro-5-[(sulphenylamino)carbonyl]-2H-tetrazolium hydroxide-based method for testing antifungal susceptibility of dermatophytes. J Clin Microbiol 46: 366871.
  • 25
    Schaller M., Borelli C., Berger U., Walker B., Schmidt S., Weindl G., Jäckel A. (2009) Susceptibility testing of amorolfine, bifonazole and ciclopirox olamine against Trichophyton rubrum in an in vitro model of dermatophytes nail infection. Med Mycol 47: 7538.
  • 26
    Barros M.E.S., Santos A., Hamdam S.J. (2007) Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A). J Med Microbiol 56: 5148.
  • 27
    Singh J., Zaman M., Aditya K. (2007) Evaluation of microdilution and disk diffusion methods for antifungal susceptibility testing of dermatophytes. Med Mycol 45: 595602.
  • 28
    Castro C., Serrano M.C., Valverde A., Pemán J., Almeida C., Martín-Mazuelos E. (2008) Comparison of the Sensititre YeastOne colorimetric antifungal panel with the modified Clinical and Laboratory Standards Institute broth microdilution (M38-A) method for antifungal susceptibility testing of dermatophytes. Chemotherapy 54: 42730.
  • 29
    Smijs T.G., Bouwstra J.A., Talebi M., Pavel S. (2007) Investigation of conditions involved in the susceptibility of the dermatophyte Trichophyton rubrum to photodynamic treatment. J Antimicrob Chemother 60: 7509.
  • 30
    Colombo A.L., Barchiesi F., McGough D.A., Rinaldi M.G. (1995) Comparison of Etest and national committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing. J Clin Microbiol 33: 53540.
  • 31
    Vanden B.H. (1997) Mechanism of antifungal resistance. Rev Iberoam Micol 14: 449.
  • 32
    Vanden B.H., Dromer F., Dromer F., Improvisi I., Lozano-Chiu M., Rex J.H., Sanglard D. (1998) Antifungal drug resistance in pathogenic fungi. Med Mycol 36: 11928.
  • 33
    Sanglard D., Kuchler K., Kuchler K., Ischer F., Pagani J.L., Monod M., Bille J. (1995) Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Ch 39: 237886.
  • 34
    Guembe M., Guinea J., Peláez T., Torres-Narbona M., Bouza E. (2007) Synergic effect of posaconazole and caspofungin against clinical zygomycetes. Antimicrob Agents Ch 51: 34578.
  • 35
    Rogari-Apiranthitou M., Mantopoulou F.D., Skiada A., Kanioura L., Grammatikou M., Vrioni G., Mitroussai-Ziouva A., Tsakris A., Petrikkos G. (2012) In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs. J Antimicrob Ch 67: 193740.
  • 36
    Gamarra S., Rocha E.M., Zhang Y.Q., Park S., Rao R., Perlin D.S. (2010) Mechanism of the synergistic effect of amiodarone and fluconazole in Candida albicans. Antimicrob Agents Ch 54: 175361.